Convalescent plasma improves survival in COVID-19 patients with blood cancers

(University of Texas Health Science Center at San Antonio) Patients with blood cancers who were hospitalized with COVID-19 fared better if they were given convalescent plasma, according to study findings from a consortium that included the Mays Cancer Center, home to UT Health San Antonio MD Anderson.